Mesothelioma - Treatment

Mm for the use of conventional therapy did not prove successful and patients have a 6个- 12 months of survival time in the introduction. Hostile acts by the clinical impact of several factors including the tendency to place through the transfer of exfoliated cells, the invasion of his subordinates and other organs within the pleural-hole for the pleural mesothelial surface and the underlying factors of extreme long period of the disease in asbestos exposure And development. Surgery Surgery, or alone or with the use of pre-and post-operative Des Voeux the combination drug therapy has proved disappointing for a five-year survival rate of less than 10 percent. Radiation Although the tumor to radiation therapy and chemotherapy is a high degree of resistance, these health, sometimes used to lift the onset of symptoms such as a transfer from the main tumor blood vessel obstruction. Chemotherapy In February 2004, was approved pemetrexed (brand name Alimta) for the treatment of malignant pleural mesothelioma. Immunotherapy Convalescence involved in immune therapy produced a volatile results. For example, intrapleural inoculation (BCG) to promote the immune response, was found not benefit the patients (when it may benefit patients). Mesothelioma cells in vitro that the impact of potential vulnerability to gradually retreat from LAK cells follow the activation of interleukin-2 (IL-2), only patient to receive such a special experience of the main side effects of therapy. Indeed, the trial suspended due to unacceptable high level of IL-2 toxicity and serious side effects such as fever and evil of sexual disease. Still, the other pilot involved in interferon alpha proved encouraging with 20 per cent of cancer patients experience of a large number of more than 50 percent and reduce the side effects were minimal integration. The passionate Intraoperative peritoneal chemotherapy Passionate approach to the intraoperative peritoneal chemotherapy famous by Paul Sugarbaker development in the Washington Cancer Institute [5]. Surgeons removed as much as possible, like many cancer chemotherapy agents was the direct management to follow, is heated to between 40 and 48.C, in the abdomen. Fluid was sprayed 60 to 120 minutes and then excretion. This technology allows the choice of the high concentration of drug management into the stomach and pelvis surface. Heated chemotherapy drugs to increase the penetration into the organization. And, more heat damage malignant cells than normal cells. Research Because mesothelioma is very difficult to control, U. S. National Cancer Institute (NCI) sponsored by the clinical trial that is designed to discover new and better ways of using the current treatment. In the new treatment may be recommended for general use, doctors conduct clinical trials to find whether the treatment is safe and effective for patients against the disease. Participation in clinical trials is an important treatment option for many patients and mesothelial